Atlas Trials

Irinotecan in Treating Patients With Refractory Metastatic Breast Cancer

Clinical trial NCT00003351 · COMPLETED

Trial details

NCT number
NCT00003351
Sponsor
Alliance for Clinical Trials in Oncology
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
1998-08-01
Primary completion
2006-10-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.